Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANDREW H LIPSKY

Allopathic & Osteopathic Physicians Internal Medicine Hematology

NPI
1982069951
CMS profile
2782987
Location
NEW YORK, NY

General Payments · PY2018–2024

$51,609.34

  • Reported across 156 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$28,112.88

49 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $8,713.31 16
BeiGene USA, Inc. $7,288.08 10
Eli Lilly and Company $7,200.00 2
Acerta Pharma LLC $3,206.72 8
BeiGene, Ltd. $963.33 1
ADC Therapeutics America, Inc. $391.47 4
Lilly USA, LLC $136.68 1
Incyte Corporation $74.99 1
Adaptive Biotechnologies Corporation $66.72 3
NOVARTIS PHARMACEUTICALS CORPORATION $44.45 2
Celgene Corporation $27.13 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,726.77 26
PY2019 $1,765.77 19
PY2020 $879.86 7
PY2021 $369.75 3
PY2022 $3,756.10 16
PY2023 $13,998.21 36
PY2024 $28,112.88 49

Payment records · PY2024 (49)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $157.00 02/12/2024 Travel and Lodging Undisputed 01/23/2026 1104888389 CMS
ABBVIE INC. $297.00 02/12/2024 Travel and Lodging Undisputed 01/23/2026 1104888391 CMS
ABBVIE INC. $378.45 02/13/2024 Travel and Lodging Undisputed 01/23/2026 1104888393 CMS
ABBVIE INC. $144.00 02/13/2024 Travel and Lodging Undisputed 01/23/2026 1104888395 CMS
ABBVIE INC. $23.07 04/16/2024 Food and Beverage Undisputed 01/23/2026 1104888397 CMS
ABBVIE INC. $38.82 05/05/2024 Food and Beverage Undisputed 01/23/2026 1104888399 CMS
ABBVIE INC. $102.22 05/21/2024 Travel and Lodging Undisputed 01/23/2026 1104888401 CMS
ABBVIE INC. $3,300.00 05/21/2024 Consulting Fee Undisputed 01/23/2026 1104888403 CMS
ABBVIE INC. $131.29 05/31/2024 Food and Beverage Undisputed 01/23/2026 1104888405 CMS
ABBVIE INC. $365.12 05/31/2024 Travel and Lodging Undisputed 01/23/2026 1104888407 CMS
ABBVIE INC. $568.93 06/01/2024 Travel and Lodging Undisputed 01/23/2026 1104888409 CMS
ABBVIE INC. $77.57 07/18/2024 Food and Beverage Undisputed 01/23/2026 1104888411 CMS
ABBVIE INC. $2,750.00 08/19/2024 Consulting Fee Undisputed 01/23/2026 1104888413 CMS
ABBVIE INC. $224.65 08/19/2024 Travel and Lodging Undisputed 01/23/2026 1104888415 CMS
ABBVIE INC. $131.67 08/19/2024 Food and Beverage Undisputed 01/23/2026 1104888417 CMS
ABBVIE INC. $23.52 09/03/2024 Food and Beverage Undisputed 01/23/2026 1104888419 CMS
Adaptive Biotechnologies Corporation $26.51 05/14/2024 Food and Beverage Undisputed 01/23/2026 1150263009 CMS
Adaptive Biotechnologies Corporation $20.07 08/27/2024 Food and Beverage Undisputed 01/23/2026 1150263011 CMS
Adaptive Biotechnologies Corporation $20.14 11/15/2024 Food and Beverage Undisputed 01/23/2026 1150263013 CMS
ADC Therapeutics America, Inc. $104.59 08/01/2024 Food and Beverage Undisputed 01/23/2026 1121193415 CMS
ADC Therapeutics America, Inc. $104.59 08/01/2024 Food and Beverage Undisputed 01/23/2026 1121193421 CMS
ADC Therapeutics America, Inc. $83.88 08/10/2024 Food and Beverage Undisputed 01/23/2026 1121193413 CMS
ADC Therapeutics America, Inc. $98.41 12/06/2024 Food and Beverage Undisputed 01/23/2026 1121193439 CMS
AstraZeneca Pharmaceuticals LP $31.16 01/10/2024 Food and Beverage Undisputed 01/23/2026 1105768014 CMS
AstraZeneca Pharmaceuticals LP $24.35 03/20/2024 Food and Beverage Undisputed 01/23/2026 1105449710 CMS
AstraZeneca Pharmaceuticals LP $28.19 07/10/2024 Food and Beverage Undisputed 01/23/2026 1105310569 CMS
AstraZeneca Pharmaceuticals LP $29.26 08/28/2024 Food and Beverage Undisputed 01/23/2026 1105723915 CMS
AstraZeneca Pharmaceuticals LP $28.76 10/09/2024 Food and Beverage Undisputed 01/23/2026 1105609069 CMS
AstraZeneca Pharmaceuticals LP $135.00 12/07/2024 Food and Beverage Undisputed 01/23/2026 1105441330 CMS
AstraZeneca Pharmaceuticals LP $60.00 12/09/2024 Food and Beverage Undisputed 01/23/2026 1104287062 CMS
AstraZeneca Pharmaceuticals LP $2,870.00 12/19/2024 Consulting Fee Undisputed 01/23/2026 1105383229 CMS
BeiGene USA, Inc. $134.57 08/02/2024 Food and Beverage Undisputed 01/23/2026 1120855692 CMS
BeiGene USA, Inc. $148.03 08/06/2024 Food and Beverage Undisputed 01/23/2026 1120855690 CMS
BeiGene USA, Inc. $2,250.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1120855688 CMS
BeiGene USA, Inc. $61.56 08/09/2024 Food and Beverage Undisputed 01/23/2026 1120855694 CMS
BeiGene USA, Inc. $3,750.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 1120855698 CMS
BeiGene USA, Inc. $675.00 11/26/2024 Consulting Fee Undisputed 01/23/2026 1120855702 CMS
BeiGene USA, Inc. $14.19 12/03/2024 Food and Beverage Undisputed 01/23/2026 1120855696 CMS
BeiGene USA, Inc. $141.29 12/05/2024 Food and Beverage Undisputed 01/23/2026 1120855704 CMS
BeiGene USA, Inc. $78.00 12/07/2024 Food and Beverage Undisputed 01/23/2026 1120855700 CMS
BeiGene USA, Inc. $35.44 12/08/2024 Food and Beverage Undisputed 01/23/2026 1120855706 CMS
BeiGene, Ltd. $963.33 01/17/2024 Consulting Fee Undisputed 01/23/2026 1120855686 CMS
Celgene Corporation $27.13 05/13/2024 Food and Beverage Undisputed 01/23/2026 1101090285 CMS
Eli Lilly and Company $4,000.00 02/02/2024 Consulting Fee Undisputed 01/23/2026 1136050859 CMS
Eli Lilly and Company $3,200.00 06/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1136039061 CMS
Incyte Corporation $74.99 08/06/2024 Education Undisputed 01/23/2026 1141283011 CMS
Lilly USA, LLC $136.68 12/08/2024 Food and Beverage Undisputed 01/23/2026 1136038973 CMS
Novartis Pharmaceuticals Corporation $21.38 01/31/2024 Food and Beverage Undisputed 01/23/2026 1087108914 CMS
Novartis Pharmaceuticals Corporation $23.07 05/13/2024 Food and Beverage Undisputed 01/23/2026 1087108924 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.